Literature DB >> 15564899

Genetic analysis of the thermolabile methylenetetrahydrofolate reductase variant in schizophrenia and mood disorders.

Ene-Choo Tan1, Siow-Ann Chong, Lionel C C Lim, Angelina O M Chan, Yik-Ying Teo, Chay-Hoon Tan, Rathi Mahendran.   

Abstract

OBJECTIVE: An elevated homocysteine level has been reported for patients with schizophrenia and depression. We investigated the frequency of the common C667 T variant of the enzyme methylenetetrahydrofolate reductase in controls and patients of Chinese descent.
METHODS: Controls with no history of mental disorder and patients diagnosed with schizophrenia, bipolar and unipolar disorders were recruited. Genomic DNA from all were genotyped for the C667 T polymorphism by polymerase chain reaction-restriction fragment length polymorphism.
RESULTS: There was no significant difference in genotype distributions or allele frequencies between controls and any of the diagnostic groups, although the frequency of the T allele was higher for all diagnostic groups and for both the male and female genders. When data was analyzed with the minor T allele as dominant, there was an excess of the T-containing genotypes in each of the patient groups compared with controls. For the difference between controls and all cases combined it almost reached statistical significance (P=0.077), with an odds ratio of 1.46 (95% confidence interval, 0.96-2.22).
CONCLUSIONS: Although there was no significant association as measured by the P value, the odds ratio and confidence interval provided some evidence of increased risk for individuals with the T-containing genotypes. A minor role for this polymorphism in the pathogenesis of schizophrenia and depression could not be ruled out and would warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15564899     DOI: 10.1097/00041444-200412000-00012

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  16 in total

Review 1.  The environment and susceptibility to schizophrenia.

Authors:  Alan S Brown
Journal:  Prog Neurobiol       Date:  2010-10-16       Impact factor: 11.685

2.  A classification of sociomedical health indicators: perspectives for health administrators and health planners.

Authors:  A E Siegmann
Journal:  Int J Health Serv       Date:  1976       Impact factor: 1.663

3.  Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatment.

Authors:  David Mischoulon; Stefania Lamon-Fava; Jacob Selhub; Judith Katz; George I Papakostas; Dan V Iosifescu; Albert S Yeung; Christina M Dording; Amy H Farabaugh; Alisabet J Clain; Lee Baer; Jonathan E Alpert; Andrew A Nierenberg; Maurizio Fava
Journal:  CNS Spectr       Date:  2012-06       Impact factor: 3.790

4.  Methylenetetrahydrofolate reductase (MTHFR) polymorphism susceptibility to schizophrenia and bipolar disorder: an updated meta-analysis.

Authors:  Cai-Yun Hu; Zhen-Zhong Qian; Feng-Feng Gong; Shan-Shan Lu; Fang Feng; Yi-Le Wu; Hui-Yun Yang; Ye-Huan Sun
Journal:  J Neural Transm (Vienna)       Date:  2014-06-18       Impact factor: 3.575

5.  Association of MTHFR C677T polymorphism with schizophrenia and its effect on episodic memory and gray matter density in patients.

Authors:  Yanling Zhang; Hao Yan; Lin Tian; Fang Wang; Tianlan Lu; Lifang Wang; Jun Yan; Qi Liu; Lan Kang; Yanyan Ruan; Dai Zhang; Weihua Yue
Journal:  Behav Brain Res       Date:  2013-01-12       Impact factor: 3.332

Review 6.  Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity.

Authors:  Simon Gilbody; Tracy Lightfoot; Trevor Sheldon
Journal:  J Epidemiol Community Health       Date:  2007-07       Impact factor: 3.710

7.  Meta-analysis of genetic association studies on bipolar disorder.

Authors:  Fayaz Seifuddin; Pamela Belmonte Mahon; Jennifer Judy; Mehdi Pirooznia; Dubravka Jancic; Jacob Taylor; Fernando S Goes; James B Potash; Peter P Zandi
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-09       Impact factor: 3.568

8.  No association of functional polymorphisms in methlylenetetrahydrofolate reductase and the risk and minor physical anomalies of schizophrenia in Korean population.

Authors:  Su-Gyeong Kim; Joo Yun Song; Eun-Jeong Joo; Seong Hoon Jeong; Se Hyun Kim; Kyu Young Lee; Nam Young Lee; Yong Min Ahn; Yong Sik Kim; Myoung-Sun Roh
Journal:  J Korean Med Sci       Date:  2011-10-01       Impact factor: 2.153

9.  Prevalence of methylenetetrahydrofolate reductase C677T polymorphism in eastern Uttar Pradesh.

Authors:  Vandana Rai; Upendra Yadav; Pradeep Kumar
Journal:  Indian J Hum Genet       Date:  2012-01

10.  C677T Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphism in Schizophrenia and Bipolar Disorder: An Association Study in Iranian Population.

Authors:  Seyed Masoud Arzaghi; Arash Hossein-Nezhad; Seyed Vahid Shariat; Alireza Ghodsipour; Jamal Shams; Bagher Larijani
Journal:  Iran J Psychiatry       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.